Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.

HERZLIYA, Israel and CALGARY, AB, March 25, 2024 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the development of drug delivery technologies using CBD for the pharmaceutical and biotechnology industries, is…